Reshma Ramachandran

18PUBLICATIONS
31CO-AUTHORS
Consumer-oriented product or service developmentPopulation trends and policiesTaxation lawPredictive and prognostic markersPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 22, 2026
Drug and country characteristics associated with global approval and launch of FDA-approved novel therapeutics.

|Jul 15, 2026
Characterizing public participation in Prescription Drug User Fee Act reauthorization, 2010-2021.

|Jan 15, 2026
Changes in pharmaceutical industry payments to physicians after New Jersey's 2018 restriction.

Neeraj G Patel, Reshma Ramachandran, Joseph S Ross

|Nov 17, 2025
Flexibility over rigor: stakeholder acceptance of the limitations of confirmatory studies following accelerated approval.

Holly Fernandez Lynch, Sejin Lee, Matthew Herder

|Oct 15, 2025
Confirmatory evidence supporting single pivotal trial new drug approvals by the Food and Drug Administration, 2015 through 2023.

Carla Barile Godoy, Reshma Ramachandran, Pradyumna Sapre

|Oct 06, 2025
Therapeutic benefit of the most expensive drugs covered by Medicare and Medicaid.

Tiffany Enxia Jiang, Reshma Ramachandran, Kerstin N Vokinger

Pageof 3

Frequent Collaborators

12 joint publications

Joseph Solomon Ross

2 joint publications

Maryam Mooghali

2 joint publications

Joshua J Skydel

2 joint publications

Sakinah Suttiratana